Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MicroMend

MicroMend
2011 FOUNDED
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE
$300K LATEST DEAL AMOUNT
11 INVESTORS
Description

Developer of wounds closure device designed to provide a new alternative to sutures and staples for skin closure. The company's device has the added feature of tiny micro staples that allow it to achieve similar holding strength to sutures, and thus close wounds currently requiring sutures or staples, enabling medical practitioners to treat skin wounds like surgical incisions and lacerations.

Formerly Known As
Marco Pharmaceuticals, Inc.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 500 Yale Avenue North
  • Suite 100
  • Seattle, WA 98109
  • United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MicroMend’s full profile, request a free trial.

MicroMend Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 24-Jun-2019 $300K 00.000 Completed Generating Revenue
6. Later Stage VC 01-Nov-2018 00.000 00.000 Completed Generating Revenue
5. Later Stage VC (Series A) 01-Jun-2018 00.000 Completed Generating Revenue
4. Later Stage VC (Series A1) 02-Mar-2017 00000 00.000 00.00 Completed Generating Revenue
3. Grant 01-Jan-2015 00.000 Completed Startup
2. Early Stage VC (Series A) 23-Dec-2014 $2.25M $2.25M 00.000 Completed Startup
1. Grant 01-Dec-2012 $1.75M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

MicroMend Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A1 0,000,000 00.000000 00.0 00.0 00 00.0 0.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

MicroMend Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gecko Biomedical Venture Capital-Backed Paris, France 00 0000 0000000000 0000
00000000 Venture Capital-Backed Caesarea, Israel 00 0000 00000000000 0000
0000000 Venture Capital-Backed San Luis Obispo, CA 00 000.00 000000000. 0 000.00
0000000 0000000 Venture Capital-Backed Campbell, CA 00 000.00 00000000000 000.00
000000000 Venture Capital-Backed Leeds, United Kingdom 00 000.00 0000000000 0 000.00
To view this company’s complete list of competitors, request access »

MicroMend Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Elevate Capital Venture Capital Minority 000 0000 000000 0
Thynk Capital Venture Capital Minority 000 0000 000000 0
Keiretsu Forum Venture Capital Minority 000 0000 000000 0
Wallace H. Coulter Foundation Limited Partner 000 0000 000000 0
Cornerstone Angels Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

MicroMend Executive Team (3)

Name Title Board
Seat
Contact
Info
Ronald Berenson MD Co-Founder, President, Chief Executive Officer and Board Member
Marco Rolandi Ph.D Co-Founder

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »

MicroMend Board Members (7)

Name Representing Role Since Contact
Info
Cameron Pollock Self Board Member 000 0000
Henry Kim Self Board Member 000 0000
Jens Quistgaard Ph.D Self Board Member 000 0000
John Brzezenski Self Board Member 000 0000
Michael Gruber Cornerstone Angels Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 7 board members. Get the full list »